Ali SA,Zaitone SA,Moustafa YM .2015 .Boswellic acids synergize antitumor activity and protect against the cardiotoxicity of doxorubicin in mice bearing Ehrlich's carcinoma. Cana J. Physio. Pharmacol., 93(8) : 695-708.
Behrouzian M,Najibi B,Haghi S,Mahdavi C,Ghaedi E .2020 .Prevalence of major cardiac events of anthracycline-induced cardiotoxicity in southwestern iran: different response patterns to cumulative dose. Cur. Drug Ther, 15(4) : 78-84.
Beniwal L,Khanna D,Dudi R,Mehan S R .2018 .Histoarchitectural and biochemical investigation of cardiac myocytes in rat model of isoproterenol-induced myocardial infarction with the exploration of boswellic acid. Pharmaspire, 10(2) : 87-94.
Geetha V,Chakravarthula SN .2018 .Chemical composition and anti-inflammatory activity of Boswellia ovalifoliolata essential oils from leaf and bark. J. Fores. Res., 29(2) : 373-381.
Griffin BR,Gist KM,Faubel S KM .2020 .Current status of novel biomarkers for the diagnosis of acute kidney injury: A historical perspective. J. Inten. Care Med, 35(5) : 415-424.
Hasinoff BB,Patel D,Wu X .2020 .The role of topoisomerase IIβ in the mechanisms of action of the doxorubicin cardioprotective agent dexrazoxane. Cardiovas. Toxicol., 20(3) : 312-320.
Henriksen PA .2018 .Anthracycline cardiotoxicity: An update on mechanisms, monitoring and prevention. Heart, 104(2) : 971-977.
Iram F,Khan SA,Husain A .2017 .Phytochemistry and potential therapeutic actions of Boswellic acids: A mini-review. Asian Pac. J. Trop. Biomed., 7(6) : 513-523.
Kelleni MT,Abdelbasset M .2018 .Drug Induced Cardiotoxicity: Mechanism, Prevention and Management. , : .
Khan MR,Khan M,Shah A .2018 .A study of heart enzyme profile in myocardial infarction. Scient. Inq. Rev., 2(2) : 01-10.
Koren O,Rozner E,Abu-Daoud I,Turgeman Y .2019 .Dynamic changes of troponin and creatine phosphokinase in acute myocarditis and non-st elevation myocardial infarction. J. Cardiovasc. Dis. Diagn., 7(6) : 2.
Liesse K,Harris J,Chan M,Schmidt ML,Chiu B .2018 .Dexrazoxane significantly reduces anthracycline-induced cardiotoxicity in pediatric solid tumor patients-a systematic review. J. Ped, 40(6) : 417.
Meier T,Gräfe K,Senn F,Sur P,Stangl GI,Dawczynski C,März W,Kleber ME,Lorkowski S ME .2019 .Cardiovascular mortality attributable to dietary risk factors in 51 countries in the WHO European Region from 1990 to 2016: A systematic analysis of the Global Burden of Disease Study. Eur. J. Epidemiol., 34(1) : 37-55.
Milwidsky A,Fisher E,Brzezinski RY,Ehrenwald M,Shefer G,Stern N,Shapira I,Zeltser D,Rosenbaum Z,Greidinger D Z .2019 .Metabolic syndrome is associated to high-sensitivity cardiac troponin T elevation. Biomarkers, 24(2) : 153-158.
Mubarak S,Hamid SA,Farrag AR,Samir N,Hussein JS .2018 .Atherogenic coefficient and atherogenic index in doxorubicin-induced cardiotoxicity: Impact of date palm extract. Comp. Clin. Path, 27 : 1515-1522.
Myburgh CE,Malan L,Wentzel A,Scheepers JDW,Malan NT .2019 .Coping and cardiac troponin T-A risk for hypertension and sub-clinical ecg left ventricular hypertrophy: The SABPA Study. , 28(6) : 908-916.
Nass RD,Motloch LJ,Paar V,Lichtenauer M,Baumann J,Zur B,Hoppe UC,Holdenrieder S,Elger CE,Surges R .2019 .Blood markers of cardiac stress after generalized convulsive seizures. Epilepsia, 60(2) : 201-210.
Niringiyumukiza JD,Cai H,Chen L,Li Y,Wang L,Zhang M,Xu X,Xiang W .2019 .Protective properties of glycogen synthase kinase-3 inhibition against doxorubicin-induced oxidative damage to mouse ovarian reserve. , 116 : 108963.
Odum EP,Wakwe VC .2017 .Clinical significance of creatine Kinase-MB elevation in patients with chronic kidney disease before initiation of hemodialysis. , 6(4) : 1-7.
Oikonomou E,Anastasiou Q,Siasos G,Androulakis E,Psyrri A,Toutouzas K,Tousoulis D K .2018 .Cancer therapeutics-related cardiovascular complications. mechanisms, diagnosis and treatment. , 24(37) : 4424-4435.
Padulo J,Nikolaidis PT,Cular D,Dello Iacono A,Vando S,Galasso M,Lo Storto D and Ardigò L P .2018 .The effect of heart rate on jump-shot accuracy of adolescent basketball players. Front, : 1065.
Pudil R,Mueller C,Celutkiene J,Henriksen PA,Lenihan D,Dent S,Barac A,Stanway S,Moslehi J,Suter TM .2020 .Role of serum biomarkers in cancer patients receiving cardiotoxic cancer therapies: A position statement from the Cardio-Oncology Study Group of the Heart Failure Association and the CardioOncology Council of the European Society of Cardiology. Eur. J. Heart Fail, 22(11) : 1966-1983.
SHAH S .2019 .Ayurveda: The Conventional Indian Medicine System and its Global practice. Himal. J. Health Sci., 4(1) : 13-33.
Shaker RA,Abboud SH,Assad HC,Hadi N HC .2018 .Enoxaparin attenuates doxorubicin induced cardiotoxicity in rats via interfering with oxidative stress, inflammation and apoptosis. BMC Pharmacol, 19(3) : 1-10.
Skubitz KM,Blaes AH,Konety SH,Francis GS .2017 .Cardiac safety profile of patients receiving high cumulative doses of pegylated-liposomal doxorubicin: use of left ventricular ejection fraction is of unproven value. Cancer Chemo, 80(4) : 787-798.
Songbo M,Lang H,Xinyong C,Bin X,Ping Z,Liang S Z .2019 .Oxidative stress injury in doxorubicininduced cardiotoxicity. Toxicol. Letters, 307 : 41-48.
Bartels MN Syrkin G. .2018 .The role of rehabilitation medicine in managing cardiopulmonary complications of cancer. Cur. Phys. Med, : 121-130.
Szmit S,Jurczak W,Zaucha JM,Długosz-Danecka M,Sosnowska-Pasiarska B,Chmielowska E,Joks M,Drozd-Sokołowska J,Knopińska-Posłuszny W,Spychałowicz W .2017 .Acute decompensated heart failure as a reason of premature chemotherapy discontinuation may be independent of a lifetime doxorubicin dose in lymphoma patients with cardiovascular disorders. Int. J. Cardiol., 235 : 147-153.
Virshette S,Patil M,Shaikh JR .2020 .A review on pharmacological properties and phytoconstituents of indigenous carminative agents. J. Pharmacog. Phytochem., 9(3) : 142-145.
Vuddanda PR,Singh S,Velaga S S .2016 .Boswellic acid-Medicinal use of an ancient herbal remedy. J. Herb. Med, 6(4) : 163-170.
Yu Y,Jin L,Zhuang Y,Hu Y,Cang J,Guo K J .2018 .Cardioprotective effect of rosuvastatin against isoproterenol-induced myocardial infarction injury in rats. Int. J. Mol. Med, 41(6) : 3509-3516.